| Title : Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease - Mehta_2005_Neurology_65_159 |
| Author(s) : Mehta KM , Yin M , Resendez C , Yaffe K |
| Ref : Neurology , 65 :159 , 2005 |
|
Abstract :
Acetylcholinesterase inhibitors (AChIs) have been demonstrated to improve Alzheimer disease symptoms. Whether the use of AChIs varies by ethnicity is unknown. More than 2500 ethnically diverse patients (6% African American, 14% Latino, and 7% Asian patients) from the Alzheimer's Disease Research Centers in California were studied. Compared with white patients with AD, minority patients had 40% lower odds of AChI use (odds ratio 0.6, 95% confidence interval: 0.5 to 0.7). |
| PubMedSearch : Mehta_2005_Neurology_65_159 |
| PubMedID: 16009909 |
Mehta KM, Yin M, Resendez C, Yaffe K (2005)
Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease
Neurology
65 :159
Mehta KM, Yin M, Resendez C, Yaffe K (2005)
Neurology
65 :159